VSIG4, a B7 family-related protein, is a negative regulator of T cell activation

被引:243
作者
Vogt, Lorenz
Schmitz, Nicole
Kurrer, Michael O.
Bauer, Monika
Hinton, Heather I.
Behnke, Silvia
Gatto, Dominique
Sebbel, Peter
Beerli, Roger R.
Sonderegger, Ivo
Kopf, Manfred
Saudan, Philippe
Bachmann, Martin F.
机构
[1] Cytos Biotechnol AG, CH-8952 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland
[3] Swiss Fed Inst Technol, Zurich, Switzerland
关键词
D O I
10.1172/JCI25673
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
T cell activation by APCs is positively and negatively regulated by members of the B7 family. We have identified a previously unknown function for B7 family-related protein V-set and Ig domain-containing 4 (VSIG4). In vitro experiments using VSIG4-Ig fusion molecules showed that VSIG4 is a strong negative regulator of murine and human T cell proliferation and IL-2 production. Administration to mice of soluble VSIG4-Ig fusion molecules reduced the induction of T cell responses in vivo and inhibited the production of Th cell-dependent IgG responses. Unlike that of B7 family members, surface expression of VSIG4 was restricted to resting tissue macrophages and absent upon activation by LPS or in autoimmune inflammatory foci. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues.
引用
收藏
页码:2817 / 2826
页数:10
相关论文
共 57 条
[1]
Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis [J].
Ahn, JH ;
Lee, Y ;
Jeon, C ;
Lee, SJ ;
Lee, BH ;
Choi, KD ;
Bae, YS .
BLOOD, 2002, 100 (05) :1742-1754
[2]
Bachmann MF, 1998, J IMMUNOL, V160, P95
[3]
Bachmann MF, 1999, J IMMUNOL, V163, P1128
[4]
Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.0.CO
[5]
2-X
[6]
Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation [J].
Bachmann, MF ;
McKallFaienza, K ;
Schmits, R ;
Bouchard, D ;
Beach, J ;
Speiser, DE ;
Mak, TW ;
Ohashi, PS .
IMMUNITY, 1997, 7 (04) :549-557
[7]
Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(2002012)32:12<3376::AID-IMMU3376>3.0.CO
[8]
2-G
[9]
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[10]
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638